INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
BIT:1ISRG - Euronext Milan - US46120E6023 - Common Stock - Currency: EUR
Overall 1ISRG gets a fundamental rating of 7 out of 10. We evaluated 1ISRG against 58 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG is valued quite expensively, but it does show have an excellent growth rating. This makes 1ISRG very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year 1ISRG was profitable.
1ISRG had a positive operating cash flow in the past year.
1ISRG had positive earnings in each of the past 5 years.
Each year in the past 5 years 1ISRG had a positive operating cash flow.
1.2 Ratios
1ISRG has a Return On Assets of 12.88%. This is amongst the best in the industry. 1ISRG outperforms 91.38% of its industry peers.
Looking at the Return On Equity, with a value of 14.47%, 1ISRG belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
1ISRG has a Return On Invested Capital of 10.45%. This is amongst the best in the industry. 1ISRG outperforms 86.21% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is above the industry average of 8.02%.
The last Return On Invested Capital (10.45%) for 1ISRG is above the 3 year average (10.24%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.88% | ||
| ROE | 14.47% | ||
| ROIC | 10.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
1.3 Margins
Looking at the Profit Margin, with a value of 28.41%, 1ISRG belongs to the top of the industry, outperforming 94.83% of the companies in the same industry.
In the last couple of years the Profit Margin of 1ISRG has declined.
1ISRG has a better Operating Margin (28.28%) than 98.28% of its industry peers.
In the last couple of years the Operating Margin of 1ISRG has declined.
1ISRG's Gross Margin of 67.09% is fine compared to the rest of the industry. 1ISRG outperforms 72.41% of its industry peers.
In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.28% | ||
| PM (TTM) | 28.41% | ||
| GM | 67.09% |
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ISRG is still creating some value.
1ISRG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1ISRG has more shares outstanding
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
1ISRG has an Altman-Z score of 54.37. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 54.37, 1ISRG belongs to the best of the industry, outperforming 98.28% of the companies in the same industry.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 54.37 |
ROIC/WACC1.17
WACC8.93%
2.3 Liquidity
1ISRG has a Current Ratio of 4.98. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.98, 1ISRG belongs to the top of the industry, outperforming 94.83% of the companies in the same industry.
1ISRG has a Quick Ratio of 3.97. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.97, 1ISRG belongs to the best of the industry, outperforming 94.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 3.97 |
3. Growth
3.1 Past
1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.76%, which is quite impressive.
Measured over the past years, 1ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
The Revenue has grown by 19.08% in the past year. This is quite good.
Measured over the past years, 1ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.27% on average per year.
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
3.2 Future
1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.45% yearly.
The Revenue is expected to grow by 14.12% on average over the next years. This is quite good.
EPS Next Y9.17%
EPS Next 2Y12.26%
EPS Next 3Y13.94%
EPS Next 5Y14.45%
Revenue Next Year18.07%
Revenue Next 2Y16.6%
Revenue Next 3Y16.14%
Revenue Next 5Y14.12%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 67.64 indicates a quite expensive valuation of 1ISRG.
1ISRG's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.15, 1ISRG is valued quite expensively.
The Price/Forward Earnings ratio is 55.96, which means the current valuation is very expensive for 1ISRG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ISRG is on the same level as its industry peers.
1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 21.60, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 67.64 | ||
| Fwd PE | 55.96 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than the industry average as 62.07% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 106.17 | ||
| EV/EBITDA | 59.61 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 13.94% in the coming years.
PEG (NY)7.38
PEG (5Y)5.89
EPS Next 2Y12.26%
EPS Next 3Y13.94%
5. Dividend
5.1 Amount
1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (6/23/2025, 7:00:00 PM)
441.7
-8.85 (-1.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.74%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap158.31B
Analysts79.49
Price Target514.87 (16.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.91%
Min EPS beat(2)3.05%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)11.89%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.01%
EPS beat(12)10
Avg EPS beat(12)4.94%
EPS beat(16)13
Avg EPS beat(16)5.44%
Revenue beat(2)2
Avg Revenue beat(2)3.11%
Min Revenue beat(2)1.09%
Max Revenue beat(2)5.12%
Revenue beat(4)2
Avg Revenue beat(4)1.5%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)0.86%
PT rev (1m)-1.92%
PT rev (3m)-17.04%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)-2.19%
EPS NY rev (1m)0.3%
EPS NY rev (3m)-2.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 67.64 | ||
| Fwd PE | 55.96 | ||
| P/S | 21.26 | ||
| P/FCF | 106.17 | ||
| P/OCF | 67.84 | ||
| P/B | 10.83 | ||
| P/tB | 11.07 | ||
| EV/EBITDA | 59.61 |
EPS(TTM)6.53
EY1.48%
EPS(NY)7.89
Fwd EY1.79%
FCF(TTM)4.16
FCFY0.94%
OCF(TTM)6.51
OCFY1.47%
SpS20.77
BVpS40.78
TBVpS39.9
PEG (NY)7.38
PEG (5Y)5.89
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.88% | ||
| ROE | 14.47% | ||
| ROCE | 13.94% | ||
| ROIC | 10.45% | ||
| ROICexc | 14.17% | ||
| ROICexgc | 14.58% | ||
| OM | 28.28% | ||
| PM (TTM) | 28.41% | ||
| GM | 67.09% | ||
| FCFM | 20.03% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
ROICexc(3y)18.39%
ROICexc(5y)17.67%
ROICexgc(3y)19.32%
ROICexgc(5y)18.71%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 185.49% | ||
| Cap/Sales | 11.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.16% | ||
| Profit Quality | 70.49% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 3.97 | ||
| Altman-Z | 54.37 |
F-Score6
WACC8.93%
ROIC/WACC1.17
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
EPS Next Y9.17%
EPS Next 2Y12.26%
EPS Next 3Y13.94%
EPS Next 5Y14.45%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
Revenue Next Year18.07%
Revenue Next 2Y16.6%
Revenue Next 3Y16.14%
Revenue Next 5Y14.12%
EBIT growth 1Y32.36%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year33.95%
EBIT Next 3Y22.85%
EBIT Next 5Y19.86%
FCF growth 1Y73.18%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y66.62%
OCF growth 3Y4.95%
OCF growth 5Y8.61%